Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Enhancing Tregs can protect against alopecia areata.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.